Evolus Lobbies Trump to Avoid U.S. Ban on its Botox Alternative

A California beauty company and its South Korean partner are lobbying the Trump administration to ensure their rival to the Botox wrinkle treatment doesn’t get frozen out of the U.S. market.
( read original story …)


Advertisement